Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Paramount Bed Holdings Co's average EPS without NRI Growth Rate was -60.60% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 1.20% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 7.60% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 5.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Paramount Bed Holdings Co was 375.10% per year. The lowest was -77.80% per year. And the median was 9.80% per year.
Paramount Bed Holdings Co (OTCPK:PBHDF) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Paramount Bed Holdings Co 3-Year EPS without NRI Growth Rate Related Terms
PBHDF vs ISRG, BDX, MDLN: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paramount Bed Holdings Co 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Paramount Bed Holdings Co's 3-Year EPS without NRI Growth Rate falls into.
Paramount Bed Holdings Co 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 1.20% mean?
Paramount Bed Holdings Co (PBHDF) has a 3-Year EPS without NRI Growth Rate of 1.20% as of Sep. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Paramount Bed Holdings Co and its competitors. This is 88% below median its historical median of 9.80.
Is Paramount Bed Holdings Co's 3-Year EPS without NRI Growth Rate too high?
Paramount Bed Holdings Co's current 3-Year EPS without NRI Growth Rate of 1.20% is 88% below median its 10-year median of 9.80. The Medical Devices & Instruments industry median 3-Year EPS without NRI Growth Rate is 8.05. Paramount Bed Holdings Co's value of 1.20% is 85.1% below this industry median. Overall, Paramount Bed Holdings Co has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's 3-Year EPS without NRI Growth Rate compare to ISRG and BDX?
Paramount Bed Holdings Co's 3-Year EPS without NRI Growth Rate of 1.20% can be compared against companies in the Medical Devices & Instruments industry. The industry median 3-Year EPS without NRI Growth Rate is 8.05. Paramount Bed Holdings Co's value of 1.20% is 85.1% below this benchmark. While the company's 10-year median is 9.80 vs. the industry median of 8.05, Paramount Bed Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 8.05, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paramount Bed Holdings Co's current 3-Year EPS without NRI Growth Rate of 1.20% is 85.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Paramount Bed Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current 3-Year EPS without NRI Growth Rate is 1.20%, which is 88% below median its own 10-year median of 9.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (PBHDF) has a current 3-Year EPS without NRI Growth Rate of 1.20%. The stock's GF Value™ is $16.33, compared to a current price of $19.74 — trading 20.9% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 1.20%, which is 88% below median its 10-year median of 9.80 and 85.1% below the Medical Devices & Instruments industry median of 8.05. Paramount Bed Holdings Co's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Paramount Bed Holdings Co (PBHDF), the current 3-Year EPS without NRI Growth Rate is 1.20% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (PBHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of $19.74 is trading 20.9% above its estimated GF Value™ of $16.33.
Key valuation signals for PBHDF:
3-Year EPS without NRI Growth Rate: 1.20% (88% below median its 10-year median of 9.80)
GF Value™: $16.33 vs. price of $19.74 (20.9% above fair value)
Industry Position: 85.1% below the Medical Devices & Instruments median
No single metric tells the full story. See the PBHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
90GF Score
Get the complete analysis for PBHDF
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBHDF has been successfully added to your 
